ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The flavor and fragrance firm Givaudan is delving deeper into synthetic biology through deals with Ginkgo Bioworks and Manus Bio. The firms aren’t sharing details, saying only that Ginkgo will aim to make “products such as those that are only available in minute quantities in nature” and that Manus will develop “natural and sustainable materials.” Both Ginkgo and Manus manipulate microorganisms to make custom small molecules, peptides, and proteins. Givaudan’s deal with Manus builds on a partnership that the firms say has yielded a food and beverage ingredient that will be available later this year.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X